Astellas Pharma Inc. (4503)

2,034.5 +20.0 (+0.99%)
Close JPY Disclaimer

4503 Earnings

Title
Quarterly
Annually
Latest Release Aug 01, 2022 Mar 31, 2022
EPS
13.59 20.86
67.05
Revenue
381.79B 344.84B
1,296.16B
Next release Date Nov 03, 2022 -
Expected growth 160.85% -
Clear All
0Selected
Please try another search
EPS
Revenue
Historical Earnings
EPS
Revenue
Forecast
Release Date
Period End
EPS Actual
EPS Forecast
EPS Surprise
Revenue Actual
Revenue Forecast
Revenue Surprise
Jul 30, 2021 06/2021 16.56 24.93 -8.37 326.14B 317.24B +8.9
Apr 27, 2021 03/2021 9.74 16.35 -6.61 317.84B 315.22B +2.62
Jan 29, 2021 12/2020 32.35 29.69 +2.66 325.43B 330.21B -4.78
Oct 30, 2020 09/2020 12.07 29.99 -17.92 308.51B 317.54B -9.03
Aug 04, 2020 06/2020 27.14 30.25 -3.11 306.97B 315.96B -8.99
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles